Clinical Trials Browser

Active not recruiting × Pancreatic Neoplasms × cabozantinib × Clear all

NCT04820179 2026-01-07

Atezolizumab + Cabozantinib in Patients w/ Metastatic, Refractory Pancreatic Cancer

Phase 2 Active not recruiting

Gastrointestinal

Pancreatic Neoplasms